Global Molecular Diagnostics Devices And Equipment Market Set To Expand To $48.84 Billion By 2030 At 12.7% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Molecular Diagnostics Devices And Equipment Market Be By 2030 Compared To Its 2026 Market Size? _x000D_
The market for molecular diagnostics devices and equipment has seen rapid expansion in recent years. This market is set to increase from $27.23 billion in 2025 to $30.33 billion in 2026, registering a compound annual growth rate (CAGR) of 11.4%. Factors contributing to its historical growth include the rise in infectious disease testing, the broadening of genetic screening programs, an increase in the use of molecular diagnostics in oncology, enhancements in sequencing accuracy, and a greater clinical awareness of molecular testing._x000D_
_x000D_
The market for molecular diagnostics devices and equipment is projected to experience substantial growth over the coming years, anticipated to reach $48.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. Factors driving this expansion during the forecast period include the rising demand for personalized medical treatments, increased investments in genomic diagnostic tools, the broadening of decentralized molecular testing, the growing acceptance of automated sample processing, and an intensified focus on identifying diseases at their early stages. Key trends expected over the forecast horizon involve the increasing uptake of PCR-based testing platforms, the growing utilization of next-generation sequencing technologies, the expanding integration of diagnostic software and bioinformatics, the broadening of companion diagnostics applications, and a heightened emphasis on early and customized diagnoses._x000D_
_x000D_
#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_
_x000D_
Which Key Factors Are Driving The Molecular Diagnostics Devices And Equipment Market Growth?_x000D_
The expansion of the molecular diagnostic devices and equipment market is anticipated to be fueled by the increasing occurrence of infectious diseases. These diseases are defined as ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of spreading between individuals or from animals to humans. The growing prevalence of infectious diseases is influenced by factors such as antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic tools and equipment are crucial for the identification and management of infectious diseases. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the incidence rate rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Therefore, the rising incidence of infectious diseases is a key driver for the growth of the molecular diagnostic devices and equipment market._x000D_
_x000D_
How Are Segments Identified Within The Molecular Diagnostics Devices And Equipment Market Segment Framework?_x000D_
The molecular diagnostics devices and equipment market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Instruments, Reagents And Consumables, Software _x000D_
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies_x000D_
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications_x000D_
4) By End User: Diagnostic laboratories, Hospitals, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays _x000D_
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials _x000D_
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation _x000D_
_x000D_
Which Trends Are Guiding The Direction Of The Molecular Diagnostics Devices And Equipment Market?_x000D_
Leading companies in the molecular diagnostics devices and equipment market are developing innovative products like high-throughput sample-to-result instruments for molecular diagnostics. These high-throughput systems will be founded upon ELITech’s established extraction and assay technology and will employ the same reagents as InGenius and BeGenius. Illustratively, in April 2023, ELITechGroup, a France-based entity involved in integrated in-vitro diagnostics, unveiled a high-throughput sample-to-result instrument for molecular diagnostics. This device facilitates continuous loading of samples and reagents alongside true random-access capability. Users will have the capacity to process diverse PCR reagents, protocols, and sample matrices simultaneously, offering maximum versatility._x000D_
_x000D_
Who Are The Companies Competing Within The Molecular Diagnostics Devices And Equipment Market?_x000D_
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd _x000D_
_x000D_
#Get The Full Molecular Diagnostics Devices And Equipment Market Report:#_x000D_
_x000D_
Which Region Has The Greatest Market Share In The Molecular Diagnostics Devices And Equipment Market?_x000D_
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request A Customized Molecular Diagnostics Devices And Equipment Market Report For Competitive Insights:#_x000D_
_x000D_
#Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company#_x000D_
_x000D_
Dental Diagnostic Imaging Devices And Equipment Market Report 2026_x000D_
_x000D_
Point Of Care Molecular Diagnostics Market Report 2026_x000D_
_x000D_
Microbiology Diagnostic Devices And Equipment Market Report 2026_x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
